Literature DB >> 28642328

Leukocyte diversity in resolving and nonresolving mechanisms of cardiac remodeling.

Bochra Tourki1, Ganesh Halade2.   

Abstract

In response to myocardial infarction (MI), time-dependent leukocyte infiltration is critical to program the acute inflammatory response. Post-MI leukocyte density, residence time in the infarcted area, and exit from the infarcted injury predict resolving or nonresolving inflammation. Overactive or unresolved inflammation is the primary determinant in heart failure pathology post-MI. Here, our review describes supporting evidence that the acute inflammatory response also guides the generation of healing and regenerative mediators after cardiac damage. Time-dependent leukocyte density and diversity and the magnitude of myocardial injury is responsible for the resolving and nonresolving pathway in myocardial healing. Post MI, the diversity of leukocytes, such as neutrophils, macrophages, and lymphocytes, has been explored that regulate the clearance of deceased cardiomyocytes by using the classic and reparative pathways. Among the innovative factors and intermediates that have been recognized as essential in acute the self-healing and clearance mechanism, we highlight specialized proresolving mediators as the emerging factor for post-MI reparative mechanisms-translational leukocyte modifiers, such as aging, the source of leukocytes, and the milieu around the leukocytes. In the clinical setting, it is possible that leukocyte diversity is more prominent as a result of risk factors, such as obesity, diabetes, and hypertension. Pharmacologic agents are critical modifiers of leukocyte diversity in healing mechanisms that may impair or stimulate the clearance mechanism. Future research is needed, with a focused approach to understand the molecular targets, cellular effectors, and receptors. A clear understanding of resolving and nonresolving inflammation in myocardial healing will help to develop novel targets with major emphasis on the resolution of inflammation in heart failure pathology.-Tourki, B., Halade, G. Leukocyte diversity in resolving and nonresolving mechanisms of cardiac remodeling. © FASEB.

Entities:  

Keywords:  heart failure; inflammation; myocardial infarction; resolution of inflammation

Mesh:

Year:  2017        PMID: 28642328      PMCID: PMC5602901          DOI: 10.1096/fj.201700109R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  140 in total

1.  Short-term disruption of diurnal rhythms after murine myocardial infarction adversely affects long-term myocardial structure and function.

Authors:  Faisal J Alibhai; Elena V Tsimakouridze; Nirmala Chinnappareddy; David C Wright; Filio Billia; M Lynne O'Sullivan; W Glen Pyle; Michael J Sole; Tami A Martino
Journal:  Circ Res       Date:  2014-03-31       Impact factor: 17.367

2.  Lower prevalence of circulating invariant natural killer T (iNKT) cells in patients with acute myocardial infarction undergoing primary coronary stenting.

Authors:  Li-Li Liu; Jia-Lan Lu; Peng-Li Chao; Li-Rong Lin; Zhong-Ying Zhang; Tian-Ci Yang
Journal:  Int Immunopharmacol       Date:  2011-01-14       Impact factor: 4.932

3.  Targeting C-reactive protein for the treatment of cardiovascular disease.

Authors:  Mark B Pepys; Gideon M Hirschfield; Glenys A Tennent; J Ruth Gallimore; Melvyn C Kahan; Vittorio Bellotti; Philip N Hawkins; Rebecca M Myers; Martin D Smith; Alessandra Polara; Alexander J A Cobb; Steven V Ley; J Andrew Aquilina; Carol V Robinson; Isam Sharif; Gillian A Gray; Caroline A Sabin; Michelle C Jenvey; Simon E Kolstoe; Darren Thompson; Stephen P Wood
Journal:  Nature       Date:  2006-04-27       Impact factor: 49.962

4.  Transforming growth factor-beta 1 inhibition of macrophage activation is mediated via Smad3.

Authors:  F Werner; M K Jain; M W Feinberg; N E Sibinga; A Pellacani; P Wiesel; M T Chin; J N Topper; M A Perrella; M E Lee
Journal:  J Biol Chem       Date:  2000-11-24       Impact factor: 5.157

5.  Macrophages are required for neonatal heart regeneration.

Authors:  Arin B Aurora; Enzo R Porrello; Wei Tan; Ahmed I Mahmoud; Joseph A Hill; Rhonda Bassel-Duby; Hesham A Sadek; Eric N Olson
Journal:  J Clin Invest       Date:  2014-02-24       Impact factor: 14.808

6.  Obesity superimposed on aging magnifies inflammation and delays the resolving response after myocardial infarction.

Authors:  Elizabeth F Lopez; Janusz H Kabarowski; Kevin A Ingle; Vasundhara Kain; Stephen Barnes; David K Crossman; Merry L Lindsey; Ganesh V Halade
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-12-05       Impact factor: 4.733

Review 7.  Macrophage death and defective inflammation resolution in atherosclerosis.

Authors:  Ira Tabas
Journal:  Nat Rev Immunol       Date:  2009-12-04       Impact factor: 53.106

8.  CCR5 signaling suppresses inflammation and reduces adverse remodeling of the infarcted heart, mediating recruitment of regulatory T cells.

Authors:  Marcin Dobaczewski; Ying Xia; Marcin Bujak; Carlos Gonzalez-Quesada; Nikolaos G Frangogiannis
Journal:  Am J Pathol       Date:  2010-04-09       Impact factor: 4.307

Review 9.  Inflammation as a therapeutic target in myocardial infarction: learning from past failures to meet future challenges.

Authors:  Amit Saxena; Ilaria Russo; Nikolaos G Frangogiannis
Journal:  Transl Res       Date:  2015-07-17       Impact factor: 7.012

Review 10.  Genetics and immunity in the era of single-cell genomics.

Authors:  Felipe A Vieira Braga; Sarah A Teichmann; Xi Chen
Journal:  Hum Mol Genet       Date:  2016-07-12       Impact factor: 6.150

View more
  26 in total

Review 1.  Obesity, Hypertension, and Cardiac Dysfunction: Novel Roles of Immunometabolism in Macrophage Activation and Inflammation.

Authors:  Alan J Mouton; Xuan Li; Michael E Hall; John E Hall
Journal:  Circ Res       Date:  2020-03-12       Impact factor: 17.367

Review 2.  Specialized Pro-Resolving Lipid Mediators: Emerging Therapeutic Candidates for Multiple Sclerosis.

Authors:  Insha Zahoor; Shailendra Giri
Journal:  Clin Rev Allergy Immunol       Date:  2021-04       Impact factor: 8.667

3.  Splenic leukocytes define the resolution of inflammation in heart failure.

Authors:  Ganesh V Halade; Paul C Norris; Vasundhara Kain; Charles N Serhan; Kevin A Ingle
Journal:  Sci Signal       Date:  2018-03-06       Impact factor: 8.192

Review 4.  Unified nexus of macrophages and maresins in cardiac reparative mechanisms.

Authors:  Jeevan Kumar Jadapalli; Ganesh V Halade
Journal:  FASEB J       Date:  2018-05-11       Impact factor: 5.191

Review 5.  Paradigm shift - Metabolic transformation of docosahexaenoic and eicosapentaenoic acids to bioactives exemplify the promise of fatty acid drug discovery.

Authors:  Ganesh V Halade; Laurence M Black; Mahendra Kumar Verma
Journal:  Biotechnol Adv       Date:  2018-02-28       Impact factor: 14.227

Review 6.  T-cell recruitment to the heart: friendly guests or unwelcome visitors?

Authors:  Robert M Blanton; Francisco J Carrillo-Salinas; Pilar Alcaide
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-05-10       Impact factor: 4.733

7.  Inhibition of FPR2 impaired leukocytes recruitment and elicited non-resolving inflammation in acute heart failure.

Authors:  Vasundhara Kain; Jeevan Kumar Jadapalli; Bochra Tourki; Ganesh V Halade
Journal:  Pharmacol Res       Date:  2019-06-16       Impact factor: 7.658

8.  Immune responsive resolvin D1 programs myocardial infarction-induced cardiorenal syndrome in heart failure.

Authors:  Ganesh V Halade; Vasundhara Kain; Charles N Serhan
Journal:  FASEB J       Date:  2018-02-13       Impact factor: 5.191

9.  Comprehensive targeted and non-targeted lipidomics analyses in failing and non-failing heart.

Authors:  Ganesh V Halade; Anela Dorbane; Kevin A Ingle; Vasundhara Kain; Jean-Marie Schmitter; Boutayna Rhourri-Frih
Journal:  Anal Bioanal Chem       Date:  2018-02-06       Impact factor: 4.142

10.  Exploring the cardiac response to injury in heart transplant biopsies.

Authors:  Philip F Halloran; Jeff Reeve; Arezu Z Aliabadi; Martin Cadeiras; Marisa G Crespo-Leiro; Mario Deng; Eugene C Depasquale; Johannes Goekler; Xavier Jouven; Daniel H Kim; Jon Kobashigawa; Alexandre Loupy; Peter Macdonald; Luciano Potena; Andreas Zuckermann; Michael D Parkes
Journal:  JCI Insight       Date:  2018-10-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.